<DOC>
	<DOCNO>NCT02923817</DOCNO>
	<brief_summary>The purpose study determine whether autologous mononuclear cell derive bone marrow effective treatment spinal cord injury .</brief_summary>
	<brief_title>Clinical Trial Using Bone Marrow-derived Mononuclear Cells Spinal Cord Injury</brief_title>
	<detailed_description>Recruitment process : The investigator select candidate study fulfill inclusion criterion violate exclusion criterion patient spinal cord injury admit department neurosurgery - Danang hospital . The investigator ask patient patient family inform consent . The patient submit informed consent participate recruit study . Procedure description : The patient move operation theater day procedure . The bone marrow patient harvest two investigator . The mononuclear cell bone marrow extract bone marrow use gravity centrifugation Ficoll Paque 1.073 . The mononuclear cell transfer 5 mL syringe hand back investigator . The investigator transplant whole cell preparation back patient lumbar injection . A final supernatant layer preparation also send lab microbiological endotoxin testing . One small portion cell preparation send laboratory cell count cluster distribution test . The patient transfer back patient room monitor outcomes 2 week , 4 week , 2 month , 4 month , 6 month . All data enter , store monitor via eCB database system TRI Cente , Kobe . Data Analysis : Primary Endpoint : A list prepared subject name AE develop , severity seriousness , causal relationship treatment , outcome . In addition , incidence AEs case 95 % confidence interval estimate . For AE type , incidence , incidence severity , incidence seriousness calculate addition estimation rate AE 95 % confidence interval case . Secondary Endpoint : Regarding secondary endpoint , Wilcoxon sign rank test use compare baseline value registration value 6 month cell transplantation . In addition , assume score secondary endpoint consecutive score , linear mixed model time point fix effect case random effect fit data registration 2 6 month cell transplantation assume appropriate covariance structure time point assess chronological change .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>1 . Patients spinal cord injury classify AB ASIA impairment scale 2 . Patients injure 3 week 1 year previously 3 . Patients partial spinal cord injury demonstrate diagnostic imaging 4 . Patients age 20 60 year acquisition inform consent 5 . Patients submit write informed consent 1 . Patients completely transect spinal cord 2 . Patients central spinal cord injury 3 . Patients organ failure SOFA score 3 point high 4 . Patients hepatitis B , hepatitis C , human immunodeficiency virus infection , leukemia infection deny 5 . Patients malignant tumour history malignant tumour within 5 year 6 . Patients follow disease/disorder : Myeloproliferative disorder myelodysplastic syndrome Poorly control ischemic heart disease Autoimmune disease Spinal stenosis Limb paralysis due central nervous system disorder attribute spinal cord injury Hepatic dysfunction Renal dysfunction Poorly control psychiatric disorder Complex multiple trauma 7 . Patients participate clinical trial complete participation within 6 month 8 . Patients pregnant possibly pregnant 9 . Other patient judge ineligible investigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>spinal cord injury</keyword>
	<keyword>autologous transplant</keyword>
	<keyword>bone marrow derive mononuclear cell</keyword>
</DOC>